{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:20:12Z","timestamp":1762521612162,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.cgh.2013.07.014","type":"journal-article","created":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T17:16:37Z","timestamp":1374599797000},"page":"1655-1660.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Alina M.","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ray","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2013.07.014_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib2","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1365-2036.2008.03812.x","article-title":"Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression","volume":"28","author":"Peyrin-Biroulet","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.07.014_bib3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/gast.1997.v112.pm9041265","article-title":"New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine","volume":"112","author":"Tilg","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.07.014_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis","volume":"113","author":"Fuss","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2013.07.014_bib5","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.52.12.1728","article-title":"A\u00a0randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis","volume":"52","author":"Tilg","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.07.014_bib6","first-page":"1807","article-title":"An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis","volume":"96","author":"Madsen","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2005.02556.x","article-title":"Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C\u00a0and inflammatory bowel disease? A case-control study","volume":"22","author":"Bargiggia","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.07.014_bib8","first-page":"597","article-title":"Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis","volume":"7","author":"Sumer","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib9","first-page":"3","article-title":"Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis","volume":"27","author":"Cottone","year":"1995","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2036.2008.03779.x","article-title":"Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C","volume":"28","author":"Scherzer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.07.014_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.crohns.2010.03.001","article-title":"Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature","volume":"4","author":"Katsanos","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2013.07.014_bib12","first-page":"1362","article-title":"[A case study: interferon-beta-induced remission of ulcerative colitis in a patient with type C chronic hepatitis]","volume":"105","author":"Miike","year":"2008","journal-title":"Jpn J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gut.2004.049940","article-title":"Acute ulcerative colitis during successful interferon\/ribavirin treatment for chronic hepatitis","volume":"54","author":"Sprenger","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.07.014_bib14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/00042737-200511000-00015","article-title":"Onset of inflammatory bowel diseases during combined alpha-interferon and ribavirin therapy for chronic hepatitis C: report of two cases","volume":"17","author":"Villa","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib15","first-page":"680","article-title":"[A case of acute phase ulcerative colitis like colitis developed by the interferon-beta therapy for chronic hepatitis C]","volume":"100","author":"Awakawa","year":"2003","journal-title":"Jpn J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib16","first-page":"399","article-title":"[A case of ulcerative colitis along with characteristic features on computed tomography (CT), developed by the treatment with interferon for chronic hepatitis C]","volume":"98","author":"Niki","year":"2001","journal-title":"Jpn J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0168-8278(01)00022-8","article-title":"Ulcerative colitis associated with interferon treatment for chronic hepatitis C","volume":"34","author":"Mavrogiannis","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib18","first-page":"54","article-title":"Interferon induced ulcerative colitis-like acute colitis","volume":"53","author":"Usami","year":"1999","journal-title":"Rinshohinyokika"},{"year":"1993","series-title":"A\u00a0case of incidence of ulcerative colitis during the therapy of interferon for hepatitis C","author":"Honda","key":"10.1016\/j.cgh.2013.07.014_bib19"},{"key":"10.1016\/j.cgh.2013.07.014_bib20","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1440-1746.2011.06890.x","article-title":"Literature review in cases with exacerbation of ulcerative colitis induced by treatment with interferon and\/or ribavirin","volume":"26","author":"Watanabe","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.crohns.2012.11.001","article-title":"Diagnosis of inflammatory bowel disease in chronic hepatitis C patients treated with pegylated interferon and ribavirin: coincidence or consequence?","volume":"7","author":"Salguiero","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2013.07.014_bib22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.crohns.2012.01.009","article-title":"Chronic hepatitis C, inflammatory bowel disease and interferon therapy","volume":"6","author":"Efe","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2013.07.014_bib23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/ibd.20152","article-title":"Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C","volume":"13","author":"Tursi","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2013.07.014_bib24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ibd.21396","article-title":"Ulcerative colitis triggered by pegylated interferon alone therapy for chronic hepatitis C","volume":"17","author":"Altnbas","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2013.07.014_bib25","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/01.aids.0000247127.19882.f6","article-title":"Crohn's disease onset in an HIV\/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin","volume":"20","author":"Bongiovanni","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.cgh.2013.07.014_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0399-8320(05)80736-5","article-title":"[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C]","volume":"29","author":"Khalil","year":"2005","journal-title":"Gastroenterologie clinique et biologique"},{"key":"10.1016\/j.cgh.2013.07.014_bib27","first-page":"1293","article-title":"[Interferon induced IBD-like acute colitis: two cases of patients with chronic active hepatitis]","volume":"92","author":"Yamamoto","year":"1995","journal-title":"Jpn J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib28","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2006.105197","article-title":"A\u00a0case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin","volume":"55","author":"Watanabe","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.07.014_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2169\/internalmedicine.32.327","article-title":"Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C","volume":"32","author":"Mitoro","year":"1993","journal-title":"Intern Med"},{"key":"10.1016\/j.cgh.2013.07.014_bib30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1572-0241.2007.01131.x","article-title":"Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a\u00a0patient with Crohn's disease","volume":"102","author":"Abdelmalek","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000094787","article-title":"Chronic hepatitis C and\u00a0Crohn's disease: nosocomial infection treatment with PEG-interferon plus ribavirin","volume":"73","author":"Salcedo-Mora","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2013.07.014_bib32","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10620-005-2875-3","article-title":"Dramatic response to granulocytapheresis in a Crohn's disease case complicated by hepatitis C virus","volume":"50","author":"Sawada","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2013.07.014_bib33","first-page":"228","article-title":"A\u00a0new treatment for HCV-ulcerative colitis comorbidity intolerant to INF-alpha","volume":"98","author":"Sawada","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.07.014_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00042737-200102000-00016","article-title":"Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection","volume":"13","author":"Campbell","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib35","first-page":"399","article-title":"[Treatment with recombinant interferon alfa-2b of a patient with chronic hepatitis C and concomitant ulcerative colitis]","volume":"89","author":"De Diego Lorenzo","year":"1997","journal-title":"Revista espanola de enfermedades digestivas"},{"key":"10.1016\/j.cgh.2013.07.014_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","article-title":"Review article: thiopurines in inflammatory bowel disease","volume":"24","author":"Derijks","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.07.014_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jac\/dki405","article-title":"Treating HCV with ribavirin analogues and ribavirin-like molecules","volume":"57","author":"Gish","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cgh.2013.07.014_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/gast.2002.31602","article-title":"Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection","volume":"122","author":"Biancone","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.07.014_bib39","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/jmv.21257","article-title":"Immune suppression leading to hepatitis C virus re-emergence after sustained virological response","volume":"80","author":"Lin","year":"2008","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cgh.2013.07.014_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0192-0561(99)00005-3","article-title":"Effects of corticosteroids on HCV infection","volume":"21","author":"Magy","year":"1999","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.cgh.2013.07.014_bib41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/lt.22417","article-title":"A\u00a0randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C","volume":"17","author":"Klintmalm","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2013.07.014_bib42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.TP.0000114610.40412.C6","article-title":"Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus","volume":"77","author":"Stangl","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2013.07.014_bib43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2011.06.031","article-title":"Immunosuppression and HCV recurrence after liver transplantation","volume":"56","author":"Samonakis","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-0676.1996.tb00768.x","article-title":"Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C","volume":"16","author":"Fukuda","year":"1996","journal-title":"Liver"},{"key":"10.1016\/j.cgh.2013.07.014_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2004.11.025","article-title":"Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study","volume":"42","author":"Zein","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2013.07.014_bib46","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.62.11.1078","article-title":"Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection","volume":"62","author":"Peterson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2013.07.014_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s10620-012-2457-0","article-title":"The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease","volume":"58","author":"Lin","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2013.07.014_bib48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"McHutchison","year":"2009","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513010550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513010550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:12:05Z","timestamp":1761541925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356513010550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1542356513010550"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2013.07.014","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2013.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}